Stock Market News3 months Annovis Bio (NYSE:ANVS) Upgraded at Maxim Group MarketBeat
Maxim Group raised shares of Annovis Bio from a “hold” rating to a “buy” rating and set a $25.00 price target on the stock in a report on Friday.
XMaxim Group raised shares of Annovis Bio from a “hold” rating to a “buy” rating and set a $25.00 price target on the stock in a report on Friday.
X